We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Sophia Genetics SA (SOPH) CHF0.05

Sell:$3.63 Buy:$3.72 Change: $0.01 (0.27%)
NASDAQ:1.75%
Market closed |  Prices as at close on 5 July 2022 | Switch to live prices |
Sell:$3.63
Buy:$3.72
Change: $0.01 (0.27%)
Market closed |  Prices as at close on 5 July 2022 | Switch to live prices |
Sell:$3.63
Buy:$3.72
Change: $0.01 (0.27%)
Market closed |  Prices as at close on 5 July 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.

Contact details

Address:
Rue du Centre 172, Saint Sulpice
LAUSANNE
1025
Switzerland
Telephone:
+41 (21) 6941060
Website:
https://www.sophiagenetics.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
SOPH
ISIN:
CH1125843347
Market cap:
$238.40 million
Shares in issue:
63.90 million
Sector:
Health Care Technology
Exchange:
NASDAQ
Country:
Switzerland
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Jurgi Camblong
    Chief Executive Officer, Founder
  • Ross Muken
    Chief Financial Officer
  • Bram Goorden
    Chief Operating Officer, Senior Vice President
  • Sergei Yakneen
    Senior Vice President, Chief Technology Officer
  • Philippe Menu
    Senior Vice President, Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.